Acknowledgements
The authors would like to thank Christian Kaiser from Richter-Helm Biologics, Hamburg, Germany, and Babatunde A. Ogunnaike,
University of Delaware for their support and for the detailed insight into their research.
KARL RIX, PHD, is the director of North American operations and MARTIN GROLMS is a technical editor in marketing and communications, both at DASGIP AG, Jülich, Germany, +49 (0)2461 980 121, m.grolms@dasgip.de
References
1. Eiteman MA, Altman E. Overcoming acetate in Escherichia coli recombinant protein fermentations, Trends Biotechnol. 2006;24(11):530–6.
2. Sorensen H, Mortensen K. (2005) Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli, Microbial
Cell Factories, 4, Available from: http://www.microbialcellfactories.com/content/4/1/1/.
3. Ramirez DM, Bentley WE. Fed-batch feeding and induction policies that improve foreign protein synthesis and stability
by avoiding stress response. Biotechnol Bioeng. 1995;47:596–608.
4. Strandberg L, Enfors S-O. Factors influencing inclusion body formation in the production of a fused protein in Escherichia
coli. Appl Env Microbiol. 1991;57(6):1669–74.
5. Choi JH, Keum KC, Lee SY. Production of recombinant proteins by high cell density cultures of Escherichia coli, Chem Eng
Sci. 2006;61:876–85.
6. Borys MC, Linzer DIH, Papoutsakis ET. Ammonia affects the glycosylation patterns of recombinant mouse placental lactogen-1
by Chinese hamster ovary cells in a pH-dependent manner. Biotechnol Bioeng. 1994;43:505–14.
7. Gawlitzek M, Estacio M, Furch T, Kiss R. Identification of Cell Culture Conditions to Control N-Glycosylation Site-Occupancy
of Recombinant Glycoproteins Expressed in CHO Cells. Biotechnology and Bioengineering. 2009;103:1164–75.
8. Hayter PM, Curling EMA, Baines AJ, Jenkins N, Salmon I, Strange PG, Tong JM, Bull AT. Glucose-limited chemostat culture
of Chinese hamster ovary cells producing recombinant human interferon-gamma. Biotechnol Bioeng. 1992;39:327–35.
9. Kunkel JP, Jan DCH, Butler M, Jamieson JC. Comparisons of the glycosylation of a monoclonal antibody produced under nominally
identical cell culture conditions in two different bioreactors. Biotechnol Progr. 2000;16:462–70.
10. Muthing J, Kemminer SE, Conradt HS, Sagi D, Nimtz M, Karst U, Peter-Katalinic J. Effects of buffering conditions and
culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. Biotechnol
Bioeng. 2003;83:321–34.
11. Senger RS, Karim MN. Effect of shear stress on intrinsic CHO culture state and glycosylation of recombinant tissue-type
plasminogen activator protein. Biotechnol Progr. 2003;19:1199–209.
12. Wong DCF, Wong KTK, Goh LT, Heng CK, Yap MGS. Impact of dynamic online fed-batch strategies on metabolism, productivity
and N-glycosylation quality in CHO cell cultures. Biotechnol Bioeng. 2005;89:164–77.
13. Yang M, Butler M. Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms. Biotechnol Progr.
2002;18:129–38.
|